{"id":1068335,"date":"2022-09-24T01:59:52","date_gmt":"2022-09-24T05:59:52","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/adverum-biotechnologies-to-participate-in-the-jefferies-cell-and-genetic-medicine-summit\/"},"modified":"2024-08-18T11:46:02","modified_gmt":"2024-08-18T15:46:02","slug":"adverum-biotechnologies-to-participate-in-the-jefferies-cell-and-genetic-medicine-summit","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/adverum-biotechnologies-to-participate-in-the-jefferies-cell-and-genetic-medicine-summit.php","title":{"rendered":"Adverum Biotechnologies to Participate in the Jefferies Cell and Genetic Medicine Summit"},"content":{"rendered":"<p><![CDATA[REDWOOD CITY, Calif., Sept.  23, 2022  (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that Peter Soparkar, chief operating officer of Adverum Biotechnologies, will present at the Jefferies Cell and Genetic Medicine Summit on September 29, 2022, at 9:30 a.m. ET.]]><\/p>\n<p>Continued here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/09\/23\/2522058\/0\/en\/Adverum-Biotechnologies-to-Participate-in-the-Jefferies-Cell-and-Genetic-Medicine-Summit.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Adverum Biotechnologies to Participate in the Jefferies Cell and Genetic Medicine Summit\">Adverum Biotechnologies to Participate in the Jefferies Cell and Genetic Medicine Summit<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Continued here: Adverum Biotechnologies to Participate in the Jefferies Cell and Genetic Medicine Summit <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/adverum-biotechnologies-to-participate-in-the-jefferies-cell-and-genetic-medicine-summit.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068335","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068335"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068335"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068335\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}